Information Library
Results for: Infectious Diseases - Enrollment & retention - Phase II/III
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Malaria Prevention in Sub-Saharan Africa
Case Study — June 24, 2011
This study enabled us to be involved in bringing a malaria vaccine to Africa which could substantially reduce an infant mortality rate that currently stands -
Advancing Prevention in Korea
Case Study — September 14, 2010
The original recruitment target and timeline were met with more than 1,100 patients screened to yield 420 randomized patients. -
Propelling Pediatric Research
Case Study — April 1, 2010
Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study -
Boosting Pediatric Enrollment
Case Study — April 1, 2010
Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks. -
Hepatitis B Vaccine-Successful Study Strategy in Asia
Case Study — November 9, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a Hepatitis B vaccine study in Asia. -
Nasal Influenza Vaccine
Case Study — September 22, 2009
Quintiles helped a customer overcome recruitment and regulatory challenges for a nasal influenza vaccine study in Argentina, Brazil and South Africa. -
Sub-Saharan Africa Phase II/III Fact Sheet
Brochure — July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
Page 1 of 1 (7 results)
